JIR
James Investment Research’s Corcept Therapeutics CORT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.07M | Hold |
14,520
| – | – | 0.13% | 145 |
|
|
2025
Q1 | $1.66M | Sell |
14,520
-3,629
| -20% | -$415K | 0.21% | 108 |
|
|
2024
Q4 | $915K | Hold |
18,149
| – | – | 0.11% | 158 |
|
|
2024
Q3 | $840K | Hold |
18,149
| – | – | 0.1% | 174 |
|
|
2024
Q2 | $590K | Sell |
18,149
-6
| -0% | -$195 | 0.07% | 199 |
|
|
2024
Q1 | $457K | Sell |
18,155
-10
| -0.1% | -$252 | 0.05% | 223 |
|
|
2023
Q4 | $590K | Hold |
18,165
| – | – | 0.07% | 191 |
|
|
2023
Q3 | $495K | Hold |
18,165
| – | – | 0.07% | 192 |
|
|
2023
Q2 | $404K | Hold |
18,165
| – | – | 0.05% | 203 |
|
|
2023
Q1 | $393K | Buy |
18,165
+5,820
| +47% | +$126K | 0.05% | 209 |
|
|
2022
Q4 | $251K | Buy |
12,345
+4,294
| +53% | +$87.3K | 0.04% | 238 |
|
|
2022
Q3 | $206K | Hold |
8,051
| – | – | 0.03% | 257 |
|
|
2022
Q2 | $191K | Buy |
+8,051
| New | +$191K | 0.03% | 260 |
|
|
2017
Q4 | – | Sell |
-117,400
| Closed | -$2.27M | – | 783 |
|
|
2017
Q3 | $2.27M | Buy |
+117,400
| New | +$2.27M | 0.08% | 212 |
|